1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BEYONDSPRING INC

BeyondSpring Inc

XNAS: BYSI

Download real time

1.70 -0.43 (-20.19%)

53.04% Fall from 52W High

110.0K XNAS Volume

High volume+loss today

XNAS 07 May, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
11S
7W
1O
2T
68.5

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

-2.1

Price to Book

Negative Price to Book
0

Beta 1Year

Very Low volatility


Insider Trading disclosures for BeyondSpring Inc

The latest disclosure was made by Patrick Fabbio in BeyondSpring Inc where a trade of 23,793 Stock Options (right to buy) done was reported to US exchanges on April 21, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Patrick Fabbio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 23,793 23,793 - - Stock Options (right to buy)
Lan Huang Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 43,630 43,630 - - Stock Options (right to buy)
Matthew Kirkby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 25,763 25,763 - - Stock Options (right to buy)
Brendan Delaney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 21,822 21,822 - - Stock Options (right to buy)
Jiangwen Majeti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 23,300 23,300 - - Stock Options (right to buy)
Sihai Xu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 19,852 19,852 - - Stock Options (right to buy)
June Lu Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 18,981 18,981 - - Stock Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters